Shire Plc, a UK speciality biopharmaceutical company, has appointed Michael Rosenblatt, MD, as a non-executive director.
Dr Rosenblatt is dean of the Tufts School of Medicine in Boston, Massachusetts. Previously, he was a professor of medicine at the Harvard Medical School and a director of the Harvard-MIT Division of Health Sciences and Technology.
His business experience includes heading a worldwide development team at Merck Sharp and Dohme Research Laboratories as well as directing drug discovery efforts in the US, Japan and Italy.
Source:
Shire press release, 24 April 2008
Copyright 2008 Evernow Publishing Ltd